cyproterone and Hamartoma

cyproterone has been researched along with Hamartoma* in 7 studies

Other Studies

7 other study(ies) available for cyproterone and Hamartoma

ArticleYear
The effect of cyproterone acetate on the growth of children with central precocious puberty.
    European journal of pediatrics, 1987, Volume: 146, Issue:5

    We have examined the growth and skeletal maturation of 19 children (6 male, 13 female) with central precocious puberty. The aetiology in nine patients (5 male, 4 female) was secondary to a hypothalamic hamartoma. Six children (2 male, 4 female) received no treatment whereas 13 children (4 male, 9 female) were treated with cyproterone acetate in a mean dose of 68 mg/m2 per day (range, 34-260) for a mean duration of 4.5 years (range, 0.8-7.9). There was no significant difference between height SDS for bone age at the beginning and end of observation in either treated or untreated groups. No significant relationship between the mean dose of cyproterone acetate used and change in height SDS for bone age could be determined. We conclude that cyproterone acetate has no beneficial effect on the growth prognosis of children with central precocious puberty.

    Topics: Body Height; Child; Child, Preschool; Cyproterone; Cyproterone Acetate; Dose-Response Relationship, Drug; Female; Hamartoma; Humans; Hypothalamic Neoplasms; Male; Prognosis; Puberty, Precocious

1987
[Long-term follow-up in a case of precocious puberty caused by hamartoma of the hypothalamus treated with cyproterone acetate].
    Minerva pediatrica, 1985, Feb-15, Volume: 37, Issue:3

    Topics: Cyproterone; Cyproterone Acetate; Follow-Up Studies; Hamartoma; Humans; Hypothalamic Neoplasms; Infant; Male; Puberty, Precocious; Time Factors; Tuber Cinereum

1985
[Diagnosis and therapy of precocious puberty in girls].
    Der Gynakologe, 1983, Volume: 16, Issue:1

    Topics: Adolescent; Androgen Antagonists; Brain Neoplasms; Child, Preschool; Cyproterone; Cyproterone Acetate; Diagnosis, Differential; Female; Hamartoma; Humans; Puberty, Precocious

1983
Medical therapy of true precocious puberty due to hamartoma of the tuber cinereum. A report of 2 cases.
    Child's brain, 1982, Volume: 9, Issue:3-4

    Topics: Child, Preschool; Cyproterone; Cyproterone Acetate; Female; Follicle Stimulating Hormone; Hamartoma; Humans; Hypothalamic Neoplasms; Infant; Luteinizing Hormone; Male; Puberty, Precocious; Tuber Cinereum

1982
Laughing seizures and precocious puberty (case report and review of the literature).
    Australian paediatric journal, 1978, Volume: 14, Issue:3

    Topics: Cerebral Ventricle Neoplasms; Child, Preschool; Cyproterone; Diagnosis, Differential; Electroencephalography; Epilepsy; Female; Hamartoma; Heart Defects, Congenital; Humans; Hypothalamo-Hypophyseal System; Hypothalamus; Laughter; Puberty, Precocious; Seizures

1978
Evaluation of the effectiveness of treatment on adult height prognosis in disorders with advanced and retarded bone age. Height and height velocity related to chronological or to bone age.
    Acta paediatrica Scandinavica, 1973, Volume: 62, Issue:4

    Topics: Age Determination by Skeleton; Androgen Antagonists; Body Height; Bone Development; Child; Child, Preschool; Cyproterone; Growth Disorders; Growth Hormone; Hamartoma; Humans; Hypopituitarism; Male; Pregnadienes; Prognosis; Puberty, Precocious; Skull Neoplasms

1973
[Sexual precocity (author's transl)].
    Journal of neuro-visceral relations, 1971, Volume: 0, Issue:0

    Topics: Acetates; Brain Diseases; Brain Neoplasms; Child; Child, Preschool; Chlormadinone Acetate; Cyproterone; Female; Hamartoma; Humans; Hypothalamus; Male; Medroxyprogesterone; Progestins; Puberty, Precocious

1971